CytRx (CYTR) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts CYTR Hot Sheet
Price: $0.09 --0%
Financial Fact:
Gain on warrant derivative liability: 246.21K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Gain on warrant derivative liability: 246.21K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
CytRx (NASDAQ: CYTR) reported Q3 EPS of ($0.10), $0.15 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on CytRx (CYTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- ResMed (RMD) Tops Q3 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
